Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Statera BioPharma Total Assets (Quarterly): 12.75M for Sept. 30, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 12.75M |
| June 30, 2022 | 13.54M |
| March 31, 2022 | 13.51M |
| December 31, 2021 | 21.17M |
| Date | Value |
|---|---|
| September 30, 2021 | 98.04M |
| June 30, 2021 | 32.10M |
| March 31, 2021 | 0.75M |
| December 31, 2020 | 1.036M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.75M
Minimum
Mar 2021
98.04M
Maximum
Sep 2021
24.11M
Average
13.53M
Median
Total Assets (Quarterly) Benchmarks
| Humanigen Inc | 5.116M |
| Cantabio Pharmaceuticals Inc | 0.3259M |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | 85.40M |
| Scopus BioPharma Inc | 0.4976M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.92M |
| Shareholders Equity (Quarterly) | -10.24M |